{"id":"https://genegraph.clinicalgenome.org/r/64602e62-b9b9-45eb-85c2-261fcfc13b87v1.0","type":"EvidenceStrengthAssertion","dc:description":"ZAP70 was first reported in relation to autosomal recessive combined immunodeficiency in 1994 (Arpaia E, et al., 1994, PMID: 8124727). ZAP70 related combined immunodeficiency is caused by abnormal T-cell receptor signaling with low to absent CD8+ T cells and normal CD3+ and CD4+ T cells numbers. Symptoms include recurrent infections, including severe lower respiratory infections and oral candidiasis, chronic diarrhea, and failure to thrive. Combined immunodeficiencies such as ZAP-70 deficiency or major histocompatibility complex (MHC) class I and II gene expression deficiency may not be detected with the TREC assay as T-cell development is intact beyond the point of T-cell receptor (TCR) gene recombination (PMID: 32579701). Six variants (missense, nonsense, frameshift, and splicing substitutions) that have been reported in six probands in six publications (PMIDs: 8124727, 28124082, 21094993, 30778343, 8202713, 8202712) are included in this curation. Variants in this gene segregated with disease in two additional family members (PMIDs: 27448562). Heterozygous carriers in these families did not show evidence of pathogenicity.The mechanism of pathogenicity is known to be loss of function. This gene-disease association is also supported by animal models, expression studies, biochemical studies, and functional studies in patient cells (PMIDs: 27869819, 8176201, 25092893, 25092893, 8124727). ZAP70 is expressed exclusively in T and NK cell lines and is expressed in all murine and human thymocyte subpopulations (PMID: 8176201). ZAP70 null mice have no detectable ZAP70 expression and absent T cells and when null mice with a tetracycline inducible Zap70 transgene are induced with Zap70 protein, thymocyte generation is partially restored (PMID: 25092893). ZAP70 interacts with the T cell receptor complex via its SH2 domains and is activated by Lck (PMID: 27869819). In summary, ZAP70 is definitively associated with autosomal recessive combined immunodeficiency. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen SCID/CID GCEP on January 20, 2022 (SOP Version 8). ","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/64602e62-b9b9-45eb-85c2-261fcfc13b87","GCISnapshot":"https://genegraph.clinicalgenome.org/r/486c47d2-e5a9-4527-a2cc-aaa43cd5c42f","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/486c47d2-e5a9-4527-a2cc-aaa43cd5c42f_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10081","date":"2022-02-08T04:48:13.125Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/486c47d2-e5a9-4527-a2cc-aaa43cd5c42f_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10081","date":"2022-02-08T04:48:24.359Z","role":"Publisher"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/486c47d2-e5a9-4527-a2cc-aaa43cd5c42f_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e209e854-2077-4057-995b-e1a4899ba164_proband_score_evidence_line","type":"EvidenceLine","direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/70ad916e-f302-4674-9d7f-323a6570314e","type":"EvidenceLine","calculatedScore":1.0,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/70ad916e-f302-4674-9d7f-323a6570314e_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"RT-PCR showed a 9nt insertion generating a 3 aa insertion in the kinase domain of the Zap-70 protein. Patient cells with this mutation had absent ZAP70 expression and activity.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/70ad916e-f302-4674-9d7f-323a6570314e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8124727","allele":{"id":"https://genegraph.clinicalgenome.org/r/5d435b25-b115-4ad4-9dc7-c96c5e3e7d32","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001079.4(ZAP70):c.1624-11G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA256743"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/e209e854-2077-4057-995b-e1a4899ba164","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8124727","rdfs:label":"P2F2","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":6,"allele":{"id":"https://genegraph.clinicalgenome.org/r/5d435b25-b115-4ad4-9dc7-c96c5e3e7d32"},"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"SSCP","phenotypes":["obo:HP_0005415","obo:HP_0004429"],"secondTestingMethod":"PCR","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/70ad916e-f302-4674-9d7f-323a6570314e_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/64f0d0f0-312b-499d-8121-66406527ace8_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2b82389d-2676-46dd-861b-886426a65989","type":"EvidenceLine","dc:description":"Nonsense variant in exon 8 of 14 predicted to result in NMD, absent in gnomAD, parents confirmed het. Same variant as in PMID: 28124082 c.het but he was Chinese and this patient is Indian so ok to count.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2b82389d-2676-46dd-861b-886426a65989_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30778343","allele":{"id":"https://genegraph.clinicalgenome.org/r/19d1c90c-7226-4b87-8137-d6cc37067770","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001079.4(ZAP70):c.847C>T (p.Arg283Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1790280"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/64f0d0f0-312b-499d-8121-66406527ace8","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30778343","rdfs:label":"P50","ageType":"AgeAtOnset","ageUnit":"Days","ageValue":304,"allele":{"id":"https://genegraph.clinicalgenome.org/r/19d1c90c-7226-4b87-8137-d6cc37067770"},"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Next generation sequencing panels","phenotypes":["obo:HP_0002028","obo:HP_0000988","obo:HP_0002716","obo:HP_0004798","obo:HP_0001508","obo:HP_0002090"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/2b82389d-2676-46dd-861b-886426a65989_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/faf32d29-7be5-4785-bf6c-edb5558e5861_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2ba682cd-45b2-4b31-bb1c-40645be25045","type":"EvidenceLine","dc:description":"Nonsense variant in exon 8 of 14 predicted to result in NMD, absent in gnomAD, maternally inherited","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2ba682cd-45b2-4b31-bb1c-40645be25045_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28124082","allele":{"id":"https://genegraph.clinicalgenome.org/r/19d1c90c-7226-4b87-8137-d6cc37067770"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/0656fc07-736a-4e84-96be-9ac0903e673c","type":"EvidenceLine","dc:description":"PTC in exon 5 of 14 predicted to result in NMD, absent in gnomAD, paternally inherited","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0656fc07-736a-4e84-96be-9ac0903e673c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28124082","allele":{"id":"https://genegraph.clinicalgenome.org/r/69c22d5d-3365-4f54-9f4d-fd7fec815629","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001079.4(ZAP70):c.598_599del (p.Leu200ValfsTer30)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573049015"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/faf32d29-7be5-4785-bf6c-edb5558e5861","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28124082","rdfs:label":"Liu male","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":7,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/69c22d5d-3365-4f54-9f4d-fd7fec815629"},{"id":"https://genegraph.clinicalgenome.org/r/19d1c90c-7226-4b87-8137-d6cc37067770"}],"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0000988","obo:HP_0003139","obo:HP_0200117","obo:HP_0002583","obo:HP_0005415","obo:HP_0033221"],"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/2ba682cd-45b2-4b31-bb1c-40645be25045_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/0656fc07-736a-4e84-96be-9ac0903e673c_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/f7cacf6b-5b69-492f-b66c-7dc1dd028c9c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d1dd639b-4d7f-4bbf-ae25-16982729b4cc","type":"EvidenceLine","dc:description":"Frameshift causing PTC in exon 12 of 14. GnomAD frequency 1/251378, parents and two unaffected siblings confirmed het and a third was WT.","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d1dd639b-4d7f-4bbf-ae25-16982729b4cc_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Mutation in transfected cultured avian cells expressed little to no ZAP70. ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/d1dd639b-4d7f-4bbf-ae25-16982729b4cc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8202712","allele":{"id":"https://genegraph.clinicalgenome.org/r/37cc56a4-48af-4e63-8a09-d8440cc072cd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001079.4(ZAP70):c.1510_1522del (p.Lys504fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA256744"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/f7cacf6b-5b69-492f-b66c-7dc1dd028c9c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8202712","rdfs:label":"Elder female","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":1,"allele":{"id":"https://genegraph.clinicalgenome.org/r/37cc56a4-48af-4e63-8a09-d8440cc072cd"},"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"PCR","phenotypes":"obo:HP_0005415","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/d1dd639b-4d7f-4bbf-ae25-16982729b4cc_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/55364e51-36e1-492c-a4c7-8d0e743ecdd3_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/14162246-e2ad-48eb-930e-3429da028265","type":"EvidenceLine","dc:description":"frameshift causing PTC in exon 8 of 14, absent in gnomAD parents confirmed het","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/14162246-e2ad-48eb-930e-3429da028265_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21094993","allele":{"id":"https://genegraph.clinicalgenome.org/r/d862dc95-22a6-46e6-8845-45d17b5b4c2a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001079.4(ZAP70):c.836_837del (p.His279ProfsTer16)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573049023"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/55364e51-36e1-492c-a4c7-8d0e743ecdd3","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21094993","rdfs:label":"Newell female","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":11,"allele":{"id":"https://genegraph.clinicalgenome.org/r/d862dc95-22a6-46e6-8845-45d17b5b4c2a"},"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0002665","obo:HP_0002716","obo:HP_0002014","obo:HP_0001744","obo:HP_0005415"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/14162246-e2ad-48eb-930e-3429da028265_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/fb6572ef-1790-4275-97d3-3b68d2c89640_proband_score_evidence_line","type":"EvidenceLine","direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d52079cd-d7b9-4d5b-b516-9be21ac3ef85","type":"EvidenceLine","calculatedScore":0.2,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d52079cd-d7b9-4d5b-b516-9be21ac3ef85_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27448562","allele":{"id":"https://genegraph.clinicalgenome.org/r/5d435b25-b115-4ad4-9dc7-c96c5e3e7d32"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/fb6572ef-1790-4275-97d3-3b68d2c89640","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27448562","rdfs:label":"P1","allele":{"id":"https://genegraph.clinicalgenome.org/r/5d435b25-b115-4ad4-9dc7-c96c5e3e7d32"},"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0004798","obo:HP_0000988","obo:HP_0005415","obo:HP_0002090"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/d52079cd-d7b9-4d5b-b516-9be21ac3ef85_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/109a31dc-1398-4795-b7eb-2dadfdee7636_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0f1d4780-286b-4fe8-b261-2f32947dc194","type":"EvidenceLine","dc:description":"Parents confirmed heterozygous. gnomad frequency 1/250846","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0f1d4780-286b-4fe8-b261-2f32947dc194_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"RT-PCR showed a 9nt insertion generating a 3 aa insertion in the kinase domain of the Zap-70 protein. Patient cells with this mutation had absent ZAP70 expression and activity.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/0f1d4780-286b-4fe8-b261-2f32947dc194_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8124727","allele":{"id":"https://genegraph.clinicalgenome.org/r/5d435b25-b115-4ad4-9dc7-c96c5e3e7d32"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/109a31dc-1398-4795-b7eb-2dadfdee7636","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8124727","rdfs:label":"P1F1","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":18,"allele":{"id":"https://genegraph.clinicalgenome.org/r/5d435b25-b115-4ad4-9dc7-c96c5e3e7d32"},"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"SSCP","phenotypes":["obo:HP_0005415","obo:HP_0004429"],"secondTestingMethod":"PCR","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/0f1d4780-286b-4fe8-b261-2f32947dc194_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/486c47d2-e5a9-4527-a2cc-aaa43cd5c42f_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/488d0b30-cd7d-4743-b39a-96159c3914d4_proband_segregation","type":"FamilyCosegregation","dc:description":"This family only has two affected individuals. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8124727","rdfs:label":"F2","estimatedLodScore":1.1,"family":{"id":"https://genegraph.clinicalgenome.org/r/488d0b30-cd7d-4743-b39a-96159c3914d4","type":"Family","rdfs:label":"F2","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/e209e854-2077-4057-995b-e1a4899ba164"}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":4,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0004429","obo:HP_0005415"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/e209e854-2077-4057-995b-e1a4899ba164"}},{"id":"https://genegraph.clinicalgenome.org/r/f92ef4c8-909e-4c3e-bd26-cfeef3ba3be6_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27448562","rdfs:label":"Schroeder family","estimatedLodScore":2.7,"family":{"id":"https://genegraph.clinicalgenome.org/r/f92ef4c8-909e-4c3e-bd26-cfeef3ba3be6","type":"Family","rdfs:label":"Schroeder family","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/fb6572ef-1790-4275-97d3-3b68d2c89640"}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":12,"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0004798","obo:HP_0000988","obo:HP_0005415","obo:HP_0002090"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/fb6572ef-1790-4275-97d3-3b68d2c89640"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/fc5b5cbb-7d7c-4489-971d-eb3fdbc854ec_proband_score_evidence_line","type":"EvidenceLine","direction":["Inconclusive","Supports"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/10ce386b-a71f-4b92-9fe3-7d91ec000b42","type":"EvidenceLine","calculatedScore":0.5,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/10ce386b-a71f-4b92-9fe3-7d91ec000b42_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Expression study in COS cells showed lower levels of ZAP70 protein (Fig 5)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/10ce386b-a71f-4b92-9fe3-7d91ec000b42_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8202713","allele":{"id":"https://genegraph.clinicalgenome.org/r/5d435b25-b115-4ad4-9dc7-c96c5e3e7d32"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/0589e088-087d-48bd-95ad-8a319f46a4f8","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0589e088-087d-48bd-95ad-8a319f46a4f8_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Expression study in COS cells showed lower levels of ZAP70 protein (Fig 5)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/0589e088-087d-48bd-95ad-8a319f46a4f8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8202713","allele":{"id":"https://genegraph.clinicalgenome.org/r/047002e7-d9f9-4dfc-9bc9-7abea17206a3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001079.4(ZAP70):c.1554C>A (p.Ser518Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA261252"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/fc5b5cbb-7d7c-4489-971d-eb3fdbc854ec","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8202713","rdfs:label":"Patient 1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":1,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/047002e7-d9f9-4dfc-9bc9-7abea17206a3"},{"id":"https://genegraph.clinicalgenome.org/r/5d435b25-b115-4ad4-9dc7-c96c5e3e7d32"}],"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"SSCP","phenotypes":["obo:HP_0002090","obo:HP_0005415","obo:HP_0002014"],"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/0589e088-087d-48bd-95ad-8a319f46a4f8_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/10ce386b-a71f-4b92-9fe3-7d91ec000b42_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/486c47d2-e5a9-4527-a2cc-aaa43cd5c42f_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/486c47d2-e5a9-4527-a2cc-aaa43cd5c42f_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b7f98d08-ff91-4cba-865d-2ae6d7efeffa","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c793b2a2-4215-459a-83b5-60acf6858148","type":"Finding","dc:description":"Both transgenic mice and humans with no ZAP70 expression have absent T cells.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25092893","rdfs:label":"Mouse model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/d7a6589f-92b3-4224-a230-ebc1c621f1a2","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/113c99c2-7432-40ea-9506-9c677efc4e0a","type":"Finding","dc:description":"Induction of Zap70 protein rescues Zap70 expression and partially restores generation of CD8 SP thymocytes. Following their withdrawal from dox diet, the frequency of F5 T cells in the blood of F5 TetZap70 chimeras underwent an exponential decay (r2=0.89) with a half life of 10.1 days (Fig. 2A). By day 40, the representation of F5 T cells in peripheral blood had dropped to <10% of their original frequency. (Fig 2)","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25092893","rdfs:label":"Mouse rescue","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/486c47d2-e5a9-4527-a2cc-aaa43cd5c42f_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5c091bf2-9d84-47d7-a5ac-2db45aa3304a","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c17f2cca-be5b-4d50-a0ca-b2418b492c1d","type":"FunctionalAlteration","dc:description":"Following cell stimulation with anti-CD3 antibodies, anti-phosphotyrosine immunoblots showed markedly decreased anti-CD3 antibody mediated stimulation of tyrosine phosphorylation. B cells demonstrated normal response. ZAP70 protein was not detectable in patient cells and ZAP70 activity was not detected.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8124727","rdfs:label":"Arpaia Functional Alteration"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/486c47d2-e5a9-4527-a2cc-aaa43cd5c42f_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dd62929c-4187-42cf-965f-d2fd86b6b05b","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5c0ff9fb-7301-4490-a6c8-3d87d0a43471","type":"Finding","dc:description":"Examination of peripheral blood T cells revealed adequate numbers ofCD4 + T cells but a marked paucity of CD8 + T cells (Fig. 1 A); very few CD3 ยง CD8 + cells could be detected (<1%). Approximately 40% of peripheral blood MNC were CD19 + B cells. Signaling through the TCR mediates changes in [Ca2+] in thymocytes, but not in peripheral T cells (Fig 2). ZAP70 is deficiency in patient derived PMBCs and thymic cell line (Fig 3). The TCR in thymocytes is sufficient in mediating signal transduction (Fig 5). ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7561679","rdfs:label":"Gelfand biochemcial signaling","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/84a386c6-2ee8-4e35-89a9-29b57065a40c","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f2ab1642-ddd8-4eb8-b804-73b96a4cf6aa","type":"Finding","dc:description":"ZAP70 is recruited to phosphorylated TCR-CD3 complexes via its SH2\ndomains, is activated by Lck and trans-autophosphorylated and released from the TCR into the plane of the plasma membrane. Now vacated TCR-binding sites are available to activate additional Zap70 molecules to amplify antigenic stimuli. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27869819","rdfs:label":"Katz interaction with TCR-CD3 complex","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/3e36a4f1-fa04-4eaa-b15b-c678e8b1eff0","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bb661f4d-5f89-4ee7-bea8-748db0b52120","type":"Finding","dc:description":"Northern blot of RNA from various organs in mice showed that ZAP70 is present exclusively in T and NK cell lines (Fig 3). ZAP70 and Syk are expressed in all murine and human thymocyte subpopulations that were examined, ranging from the most immature CD4- CD8- stage to the mature single positive stage (Fig 4). Human T cells were isolated and stimulated with PMA to see if stimulation affected expression and expression of ZAP70 and Syk were not affected by T-cell stimulation (Fig 8). ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8176201","rdfs:label":"Chan expression","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6}],"evidenceStrength":"Definitive","sequence":3949,"specifiedBy":"GeneValidityCriteria8","strengthScore":18,"subject":{"id":"https://genegraph.clinicalgenome.org/r/gQtCz1UCNmI","type":"GeneValidityProposition","disease":"obo:MONDO_0010023","gene":"hgnc:12858","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_486c47d2-e5a9-4527-a2cc-aaa43cd5c42f-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}